Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v2.4.0.8
Document and Entity Information
9 Months Ended
Sep. 30, 2013
Oct. 30, 2013
Document and Entity Information    
Entity Registrant Name RIGEL PHARMACEUTICALS INC  
Entity Central Index Key 0001034842  
Document Type 10-Q  
Document Period End Date Sep. 30, 2013  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Filer Category Accelerated Filer  
Entity Common Stock, Shares Outstanding   87,430,342
Document Fiscal Year Focus 2013  
Document Fiscal Period Focus Q3